Cord Blood Power and the Definition of Success After BMT

Overview

Journal Blood Adv

Specialty Hematology

Date 2022 Nov 9

PMID 36350719

Authors

Jaap Jan Boelens

Andromachi Scaradavou

Affiliations

Soon will be listed here.

References

Admiraal R, Nierkens S, Bierings M, Bredius R, van Vliet I, Jiang Y . Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial. Lancet Haematol. 2022; 9(2):e111-e120. DOI: 10.1016/S2352-3026(21)00375-6. View

de Koning C, Gabelich J, Langenhorst J, Admiraal R, Kuball J, Boelens J . Filgrastim enhances T-cell clearance by antithymocyte globulin exposure after unrelated cord blood transplantation. Blood Adv. 2018; 2(5):565-574. PMC: 5851423. DOI: 10.1182/bloodadvances.2017015487. View

Pai S, Logan B, Griffith L, Buckley R, Parrott R, Dvorak C . Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med. 2014; 371(5):434-46. PMC: 4183064. DOI: 10.1056/NEJMoa1401177. View

Bartelink I, Lalmohamed A, van Reij E, Dvorak C, Savic R, Zwaveling J . Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis. Lancet Haematol. 2016; 3(11):e526-e536. PMC: 5159247. DOI: 10.1016/S2352-3026(16)30114-4. View

Flinsenberg T, Spel L, Jansen M, Koning D, de Haar C, Plantinga M . Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation. J Virol. 2014; 89(2):1058-69. PMC: 4300625. DOI: 10.1128/JVI.01850-14. View

Eapen M, Wang T, Veys P, Boelens J, Martin A, Spellman S . Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis. Lancet Haematol. 2017; 4(7):e325-e333. PMC: 5699478. DOI: 10.1016/S2352-3026(17)30104-7. View

Hiwarkar P, Gaspar H, Gilmour K, Jagani M, Chiesa R, Bennett-Rees N . Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients. Bone Marrow Transplant. 2012; 48(6):803-8. DOI: 10.1038/bmt.2012.221. View

Albert M, Slatter M, Gennery A, Gungor T, Bakunina K, Markovitch B . Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis. Blood. 2022; 139(13):2066-2079. DOI: 10.1182/blood.2021014687. View

Chiesa R, Gilmour K, Qasim W, Adams S, Worth A, Zhan H . Omission of in vivo T-cell depletion promotes rapid expansion of naïve CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant. Br J Haematol. 2012; 156(5):656-66. DOI: 10.1111/j.1365-2141.2011.08994.x. View

10.

Politikos I, Lavery J, Hilden P, Cho C, Borrill T, Maloy M . Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin. Blood Adv. 2020; 4(1):191-202. PMC: 6960461. DOI: 10.1182/bloodadvances.2019000836. View

11.

Admiraal R, Lindemans C, van Kesteren C, Bierings M, Versluijs A, Nierkens S . Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation. Blood. 2016; 128(23):2734-2741. DOI: 10.1182/blood-2016-06-721936. View

12.

Martinez C, Aguayo-Hiraldo P, Chaimowitz N, Forbes L, Rider N, Nicholas S . Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival. Blood Adv. 2022; 7(9):1823-1830. PMC: 10165184. DOI: 10.1182/bloodadvances.2022009038. View